Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Ferro

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
QJM : Monthly Journal of the Association of Physicians|October 17, 2006
The treatment of coronary artery disease in patients with chronic kidney diseaseN C Edwards, R P Steeds, C J Ferro, et al.
Heart (British Cardiac Society)|March 1, 2008
Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fractionN C Edwards, C J Ferro, J N Townend, et al.
Palliative Medicine|June 29, 2011
A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines projectS King, K Forbes, G W Hanks, et al.
British Journal of Pharmacology|September 1, 1996
The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044C Plumpton, C J Ferro, W G Haynes, et al.
Clinical Pharmacology and Therapeutics|August 17, 2000
Big endothelin-3 constricts forearm resistance vessels but not hand veins in humansC J Ferro, F E Strachan, E Shepherd, et al.
Heart (British Cardiac Society)|May 21, 2010
Reduction of blood pressure already in the normal range further regresses left ventricular massC D Chue, N C Edwards, C J Ferro, et al.
Journal of Human Hypertension|July 19, 2013
Spironolactone increases serum uric acid levels in patients with chronic kidney diseaseS E Cabrera, N C Edwards, R P Steeds, et al.
Clinical Radiology|October 14, 2016
Re: assessment of myocardial fibrosis with T1 mapping MRIM K Hayer, C J Ferro, J N Townend, et al.
QJM : Monthly Journal of the Association of Physicians|September 21, 2011
Unexpected benefits of participation in a clinical trial: abdominal aortic aneurysms in patients with chronic kidney diseaseC D Chue, W E Moody, R P Steeds, et al.
QJM : Monthly Journal of the Association of Physicians|October 16, 2019
Cytomegalovirus seropositivity is independently associated with cardiovascular disease in non-dialysis dependent chronic kidney diseaseA H K Karangizi, D Chanouzas, A Fenton, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
QJM : Monthly Journal of the Association of Physicians|October 17, 2006
The treatment of coronary artery disease in patients with chronic kidney diseaseN C Edwards, R P Steeds, C J Ferro, et al.
Heart (British Cardiac Society)|March 1, 2008
Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fractionN C Edwards, C J Ferro, J N Townend, et al.
Palliative Medicine|June 29, 2011
A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines projectS King, K Forbes, G W Hanks, et al.
British Journal of Pharmacology|September 1, 1996
The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044C Plumpton, C J Ferro, W G Haynes, et al.
Clinical Pharmacology and Therapeutics|August 17, 2000
Big endothelin-3 constricts forearm resistance vessels but not hand veins in humansC J Ferro, F E Strachan, E Shepherd, et al.
Heart (British Cardiac Society)|May 21, 2010
Reduction of blood pressure already in the normal range further regresses left ventricular massC D Chue, N C Edwards, C J Ferro, et al.
Journal of Human Hypertension|July 19, 2013
Spironolactone increases serum uric acid levels in patients with chronic kidney diseaseS E Cabrera, N C Edwards, R P Steeds, et al.
Clinical Radiology|October 14, 2016
Re: assessment of myocardial fibrosis with T1 mapping MRIM K Hayer, C J Ferro, J N Townend, et al.
QJM : Monthly Journal of the Association of Physicians|September 21, 2011
Unexpected benefits of participation in a clinical trial: abdominal aortic aneurysms in patients with chronic kidney diseaseC D Chue, W E Moody, R P Steeds, et al.
QJM : Monthly Journal of the Association of Physicians|October 16, 2019
Cytomegalovirus seropositivity is independently associated with cardiovascular disease in non-dialysis dependent chronic kidney diseaseA H K Karangizi, D Chanouzas, A Fenton, et al.
Pageof 4